share_log

UroGen Pharma Q1 EPS $(0.97) Misses $(0.87) Estimate, Sales $18.78M Miss $21.38M Estimate

Benzinga ·  May 13 08:01

UroGen Pharma (NASDAQ:URGN) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.87) by 11.49 percent. This is a 25.38 percent increase over losses of $(1.30) per share from the same period last year. The company reported quarterly sales of $18.78 million which missed the analyst consensus estimate of $21.38 million by 12.16 percent. This is a 9.24 percent increase over sales of $17.19 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment